Lys340
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Ubiquitylation Site Page:
Lys340 - HLAA iso36 (human)

Site Information
RRKSSDRkGGSYTQA   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: HLAA iso31 (human): K340, HLAA iso25 (human): K340, HLAA (human): K340, HLAA iso3 (human): K340, HLAA iso23 (human): (K340), HLAA iso80 (human): (K340), HLAA (mouse): (‑), HLAA iso24 (human): (K340)
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 12319454

In vivo Characterization
Methods used to characterize site in vivo: mass spectrometry (1, 2, 3)
Disease tissue studied: lung cancer (1), non-small cell lung adenocarcinoma (1)
Relevant cell line - cell type - tissue: A549 (pulmonary) (1), Jurkat (T lymphocyte) (2)




References

1

Wu Q, et al. (2015) Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line. Sci Rep 5, 9520
25825284   Curated Info

2

Mertins P, et al. (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10, 634-7
23749302   Curated Info

3

Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44, 325-40
21906983   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.